An FDA advisory panel voted 5-to-8 to recommend rejecting a new drug for patients hospitalized with Covid-19, ruling that a glimmer of potential life-saving benefit couldn’t make up for a long list of questions around the company’s main trial.
The debate centered around sabizabulin, a molecule originally put in development for cancer but repurposed during the pandemic. In April, the drug made headlines after its developer, Veru Inc, announced that it dramatically slashed deaths in a clinical trial of severe Covid patients: Nearly half of patients on placebo died, compared to 20% on the drug.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED"severe" - Google News
November 10, 2022 at 06:38AM
https://ift.tt/yq67Jm5
FDA panel votes against Veru's drug for severe Covid - STAT
"severe" - Google News
https://ift.tt/eqf8nS0
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "FDA panel votes against Veru's drug for severe Covid - STAT"
Post a Comment